Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

PRLD — Prelude Therapeutics Incorporated Dilution Risk Tracker

Track PRLD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRLD — Get alerts when the score changes →

As of October 13, 2026, Prelude Therapeutics Incorporated (PRLD) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Prelude Therapeutics Incorporated has a market capitalization of $298.47M, 79.80M shares outstanding, 57 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $25.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
27
💰 Cash Runway
40
📊 Float Risk
65
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 13%
💰 Capital Raise model 18%
• Active ATM program with $25M remaining capacity
🔄 Reverse Split model est. 15%
• 52-week low $0.75 has breached $1
🔔 Track PRLD — Get forecast alerts →

Market Data

Market Cap$298.47M
Shares Outstanding79.80M
Float22.96M
Cash$151.76M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding79.80MVerified float table or market cache
Public Float22.96MVerified float table or market cache
Market Cap$298.47MMarket data cache
Cash Runway15.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$25.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 2, 4 1, 424B5 1, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 8.3% shares (2026Q1 vs prior)
57 institutional holders · 33.15M shares
#1 ORBIMED ADVISORS LLC 10.91M shares
#2 BAKER BROS. ADVISORS LP 10.12M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.46M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.58M
Days to Cover7.9
% of Float19.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-03-16
3 FORM3 2026-04-15
3 FORM3 2026-03-19
8-K 8K EVENT 2026-03-12
424B5 ATM 2026-03-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PRLD Dilution Snapshot

Prelude Therapeutics Incorporated (PRLD) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PRLD's DilutionScore is currently 43/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 51/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202643/100MEDIUM53 days
Jul 17 – Aug 21, 202651/100HIGH35 days
Jul 16, 202650/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PRLD shares outstanding have increased 48.3% from 43.77M (Mar 2026) to 64.92M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202664.92M22.96M▲ 109.27%
May 11, 202664.91M10.97M▼ 53.86%
May 01, 202664.91M23.78M▼ 18.27%
Apr 26, 202643.77M29.09M▲ 99.81%
Mar 23, 202643.77M14.56M▼ 0.68%
Mar 17, 202643.77M14.66M▼ 10.77%
Mar 15, 202643.77M16.43M▲ 3.54%
Mar 14, 202643.77M15.87M▼ 3.26%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PRLD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PRLD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PRLD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PRLD
PRLD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.